Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
We appreciate the comments by Fujii and colleagues in reference to our manuscript on the development and validation of the BARD score for identifying patients with non-alcoholic steatohepatitis (NASH) without advanced fibrosis1 and applaud efforts by other investigators to apply the BARD score to their patient populations. The authors conclude that in a study of 122 Japanese patients with non-alcoholic fatty liver …
Competing interests None.
Provenance and Peer review Not commissioned; not externally peer reviewed.